Compounded Ophthalmic Formulations

Similar documents
Compounded Ophthalmic Formulations

Optometry Act, 1991 Loi de 1991 sur les optométristes

ONTARIO REGULATION 112/11 made under the OPTOMETRY ACT, 1991 Made: December 8, 2010 Approved: March 23, 2011 Filed: April 5, 2011 Published on

INJECTION GMP FSC AMPICILLIN SODIUM 500mg/1 g+ SULBACTAM DRY POWDER INJECTION GMP FSC

BIO4 Antibiotics Expert Committee

Fundamentals of Pharmacology for Veterinary Technicians Chapter 18

GOBIERNO DE PUERTO RICO Administración de Servicios Médicos de Puerto Rico

PHLOX LABORATORIES PRIVATE LIMITED 1. Hematinic Syrup of Iron, Folic acid and Vitamin B12 (For therapeutic use)

ARCI Controlled Therapeutic Medication Schedule for Horses - Version 2.2 Revised April 2015

New Maryland Racing Medication Guidelines

CONCORD DRUGS LIMITED Hyderabad

ARCI Controlled Therapeutic Medication Schedule for Horses - Version 3.2 Revised December 9, 2016.

ARCI Controlled Therapeutic Medication Schedule for Horses - Version 4.1 Revised January, 2019

SESSION 2 8:45 10am. In-office Procedures. Contraindications to Injection. Introduction Joint and Soft Tissue Injection. Learning Objective

THE ADVANTAGES OF cgmp Manufactured Veterinary Drugs

Pharmacy Program Updates: Quarterly Pharmacy Changes Effective Oct. 1, 2017

A Pet Owner s Guide to Joint Health for Dogs

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Cascade. Guide for veterinarians if NO authorised medicinal product is available. Federation of Veterinarians of Europe

Maryland Racing Commission Medication Guidelines

Availability of Veterinary Medicines. Availability of Veterinary Medicines. Using the Cascade and Essential List for Equidae

COMMUNITY MEDICINE PHARMACY

Joint Health Supplement

Subject: Updated and Revised Federal Upper Limits List

GUIDE TO THE PROFESSIONAL PRACTICE STANDARD

Commonly Used Therapeutic Drugs in Rodents

American Veterinary Medical Association

ISMP Canada HYDROmorphone Knowledge Assessment Survey

Public Assessment Report. Scientific discussion. Xiflodrop 5 mg/ml eye drops, solution. Moxifloxacin hydrochloride DK/H/2221/001/DC

Fundamentals of Pharmacology for Veterinary Technicians Chapter 16

Dosing Your Cat with Azithromycin Pediatric Suspension. By Lorraine Shelton

WITHDRAWAL TIME RECOMMENDATIONS ARIZONA RACE TRACKS MEET

Equine Pharmaceuticals: Manufacturing/ Compounding Issues. Legal and Ethical Veterinary Compounding. Horse Industry Integrity

50mg per 1000 tablets. 300mg per 1000 tablets. 100mg/ml 10ml per 100 amps. 200mg per 1000 tablets 400mg per 1000 tablets. 500mg per 1000 tablets

UAB Controlled Substances Program Catalog Numbers by Vendor. Catalog # Brand Name Generic Name Schedule Amount Manufacturer Unit Cost Henry Schein

UAB Controlled Substances Program Catalog Numbers by Vendor. Henry Schein charges a $5 fee for any order under $75

Dropless Cataract Surgery Update

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

Registered Drug Product List:

The College of Veterinarians of Ontario. Guidelines. for the Compounding of Veterinary Drugs

Bulletin #33. Manitoba Drug Benefits and Interchangeability Formulary Amendments.

Doxycycline hyclate vs monohydrate

Table 2 - Medications and their ideal route of administration

IMPORTANT SAFETY INFORMATION

Full Coverage. Best Practice. Digital magazine

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE RESPONSE TO OFFICE ACTION

YOUR COMPLETE SOURCE FOR MEDICAL MISSIONS SUPPLIES.

20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 50mL, 100mL. 50mL, 100mL.

PRODUCTS LIST INFECTIOLOGY


Drug Class Literature Scan: Otic Antibiotics

No 6 Ophtha Dt. 23/02/1019. QUOTATION CALL No-1

All India Ophthalmological Society members survey results: Cataract surgery antibiotic prophylaxis current practice pattern 2017

Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules

SUMMARY OF PRODUCT CHARACTERISTICS

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

Pharmaceutical issues relating to STI s. June Minton Lead HIV/GUM & Infectious Diseases Pharmacist University College London Hospitals NHS Trust

INVITATION TO BID BL038-18

Veterinary medicines. Prescriptions 2. Dispensing veterinary medicines 3. Storage of poisons and restricted substances 5

Prescription Medications Alphabetical Listing

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC)

Pradhan Prasanna Kumar et al. Int. Res. J. Pharm. 2014, 5 (9) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

STANDARD OPERATING PROCEDURE #701 MACAQUE RELATED INJURY

MEDICINES CONTROL COUNCIL

PROFESSIONAL PRACTICE STANDARD

Meloxicam withdrawal time veterinarian bovine


Griseofulvin 500 mg microsize tablet Grifulvin V


BASICS OF VETERINARY COMPOUNDING Presented By: Stephanie Montoya, MBA, BS, CPhT.

PRESCRIBING INFORMATION

A first-line treatment for ear infections in children with ear tubes*

LABELLING AND PACKAGE LEAFLET

STANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA

Bureau of Laboratory Quality Standards Page 1 of 10

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

- the details, where possible, of the antibiotic products these companies supply or have supplied.

Proceedings of the 56th Annual Convention of the American Association of Equine Practitioners - AAEP -

YOUR COMPLETE SOURCE FOR MEDICAL MISSIONS SUPPLIES.

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

SUMMARY OF PRODUCT CHARACTERISTICS

OPHTHALMIC DRUGS: WHICH ONES, WHEN, WHY AND WHY NOT? Rachel Matusow, DVM, DACVO Cornell University Veterinary Specialists.

Medicine / Pharmaceuticals CATALOGUE

A New Advancement in Anesthesia. Your clear choice for induction.

SUMMARY OF PRODUCT CHARACTERISTICS

Single-Dose Toxicity Study in Beagle or Mixed Breed Dogs. MTD Determination with Repeat Dose Range-Finding in Beagle or Mixed Breed Dogs

Is Tobramycin Ophthalmic Solution Usp 0.3 Used For Pink Eye

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Compliance. Should you have any questions, please contact Praveen Pabba, Ph.D., ( or

FREEDOM OF INFORMATION (FOI) SUMMARY

Day 90 Labelling, PL LABELLING AND PACKAGE LEAFLET

What s New NPPA has fixed/revised ceiling prices/retail Prices of 65 formulations under Drugs

Veterinary. Kevin Oberlander, RPh Deborah Clark, RPh Chris Simmons, RPh International Seminar Houston, TX November 10 12, 2016

Topical Antibiotic Update. Brad Sutton, O.D., F.A.A.O. Indiana University School of Optometry Indianapolis Eye Care Center No financial disclosures

Ndc code for dexamethasone acetate

Veterinary Pharmacy An Introduction Jennifer A. Kelleher, PharmD, BCPS, FSVHP Compounding Pharmacist

LUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification MADE IN INDIA

Package leaflet: Information for the user. GENTAMICIN VISION 3 mg/ml eye drops, solution Gentamicin

Transcription:

Compounded Ophthalmic Formulations Pricing is updated as of February 2018 and may be subject to change

PCAB-ACCREDITED 503A PHARMACY PATIENT SPECIFIC Topical Formulations (Con't) Simple Drops Formulations Concentration Unit Size Price Lat (Latanoprost) PF Dor (Dorzolamide) PF Tim-Lat (Timolol and latanoprost) PF Brim-Dor (Brimonidine and dorzolamide) PF Dor-Tim (Dorzolamide and Timolol) PF Tim-Brim-Dor (Timolol, brimonidine and dorzolamide) PF Tim-Dor-Lat (Timolol, dorzolamide and latanoprost) PF Tim-Brim-Dor-Lat (Timolol, brimonidine, dorzolamide and latanoprost) PF Triple/Quad Kit 0.005% 7.5mL 2% 10mL (0.5/0.005)% 5mL (0.15/2)% 10mL (2/0.5)% 10mL (0.5/0.15/2)% 10mL (0.5/2/0.005)% 5mL (0.5/0.15/2/0.005)% 5mL $69.00 per bottle ($23.00 per 2.5mL) $60.00 per bottle ($30.00 per 5mL) $98.00 per bottle ($49.00 per 2.5mL) $98.00 per bottle ($49.00 per 5mL) $94.00 per bottle ($47.00 per 5mL) $118.00 per bottle ($59.00 per 5mL) $118.00 per bottle ($59.00 per 2.5mL) $138.00 per bottle ($69.00 per 2.5mL) $158.00 per kit Tim-Brim-Dor (0.5/0.15/2)% 10mL Tim-Brim-Dor-Lat (0.5/0.15/2/0.005)% 5mL Total Tears Formulations Concentration Unit Size Price Chondroitin Sulfate Ophthalmic Solution PF n/a 10mL $20.00 per bottle Cyclosporine/Chondroitin Sulfate Ophthalmic Emulsion PF 0.1% 16.5mL $150.00/3 bottles ($50.00 per bottle) PF = Preservative Free *For professional use only. Imprimis Pharmaceuticals specializes in customizing medications to meet unique patient and practitioner needs. Imprimis Pharmaceuticals dispenses these formulations only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. Imprimis Pharmaceuticals does not compound copies of commercially available products. References available upon request.

Injectable Formulations PCAB-ACCREDITED 503A PHARMACY PATIENT SPECIFIC Dropless Formulations Concentration Unit Size Price Tri-Moxi (Triamcinolone acetonide and moxifloxacin hydrochloride) Dex-Moxi (Dexamethasone and moxifloxacin hydrochloride) Dex-Moxi-Ketor (Dexamethasone, moxifloxacin hydrochloride and ketorolac) 15mg/1mg/mL Single-Use Vial $22.00 per vial 1mg/5mg/mL Single-Use Vial $25.00 per vial 1mg/0.5mg/0.4mg/mL Single-Use Vial $27.50 per vial Moxifloxacin 5mg/mL Single-Use Vial $15.00 per vial Other Injectable Formulations Concentration Unit Size Price Hyaluronidase 300U/mL Single-Use Vial $24.00 per vial Lidocaine/Epinephrine in BSS (PF/SF) (0.75/0.025)% Single-Use Vial $25.00 per vial Phenylephrine/Lidocaine (PF/SF) (1.5/1)% Single-Use Vial $18.00 per vial Topical Formulations LessDrops Formulations (ship to physician) Concentration Unit Size Price Pred-Gati (Prednisolone acetate and gatifloxacin) Pred-Brom (Prednisolone acetate and bromfenac) (1/0.5)% 3.5mL $32.00 per bottle (1/0.5/0.075)% 3.5mL $38.00 per bottle (1/0.5/0.075)% 7mL $70.00 per bottle (1/0.075)% 3.5mL $32.00 per bottle SF = Sulfite Free PF = Preservative Free *For professional use only. Imprimis Pharmaceuticals specializes in customizing medications to meet unique patient and practitioner needs. Imprimis Pharmaceuticals dispenses these formulations only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. Imprimis Pharmaceuticals does not compound copies of commercially available products. References available upon request.

PCAB-ACCREDITED 503A PHARMACY PATIENT SPECIFIC Topical Formulations (Con't) Other Topical Formulations Concentration Unit Size Price Mydriatic 3 (Tropicamide, cyclopentolate and phenylephrine) (1/1/2.5)% 1mL $17.00 per bottle Mydriatic 4 (Tropicamide, proparacaine, phenylephrine and ketorolac) (1/0.5/2.5/0.5)% 1mL $17.00 per bottle Povidone Iodine 5% 1mL $8.00 per bottle Atropine Sulfate 0.01% 5mL $59.00 per bottle Oral Formulations IV Free Formulations Concentration Unit Size Price MKO Melt Sublingual Lemon (Midazolam, ketamine HCl and ondansetron) (3/25/2)mg 1 Melt $15.00 Total Tears Formulations Concentration Unit Size Price Omega-3 AR 500mg 360 capsules $156.00 Omega-3 AR/Doxycycline 10mg 180 capsules $109.00 *For professional use only. Imprimis Pharmaceuticals specializes in customizing medications to meet unique patient and practitioner needs. Imprimis Pharmaceuticals dispenses these formulations only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. Imprimis Pharmaceuticals does not compound copies of commercially available products. References available upon request.

503B FDA-REGISTERED OUTSOURCING FACILITY NON-PATIENT SPECIFIC All formulations purchased from our FDA-Registered Outsourcing Facility are available at the prices indicated below. Injectable Formulations Dropless Formulations Concentration Unit Size Package Size Price Tri-Moxi (Triamcinolone and moxifloxacin hydrochloride) Dex-Moxi (Dexamethasone and moxifloxacin hydrochloride) 15mg/1mg/mL Single-Use Vial 20 vials $440 per box 1mg/5mg/mL Single-Use Vial 20 vials $500 per box Dex-Moxi-Ketor (Dexamethasone, moxifloxacin hydrochloride and ketorolac) 1mg/0.5mg/0.4mg/mL Single-Use Vial 20 vials $550 per box Moxifloxacin 5mg/mL Single-Use Vial 20 vials $300 per box Other Injectable Formulations Concentration Unit Size Package Size Price Lidocaine/Epinephrine in BSS (PF/SF) Coming Soon (0.75/0.025)% Single-Use Vial Topical Formulations LessDrops Formulations Concentration Unit Size Package Size Price Pred-Gati (Prednisolone acetate and gatifloxacin) Pred-Brom (Prednisolone acetate and bromfenac) (1/0.5)% 3.5mL 20 bottles $640 per box (1/0.075)% 3.5mL 20 bottles $640 per box (1/0.5/0.075)% 3.5mL 20 bottles $760 per box (1/0.5/0.075)% 7mL 20 bottles $1,400 per box FREE GROUND SHIPPING FOR ALL 503B ORDERS *For professional use only. Imprimis Pharmaceuticals specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. Imprimis Pharmaceuticals does not compound copies of commercially available products. References available upon request.

503B FDA-REGISTERED OUTSOURCING FACILITY NON-PATIENT SPECIFIC All formulations purchased from our FDA-Registered Outsourcing Facility are available at the prices indicated below. Topical Formulations (Con t) Other Topical Formulations Concentration Unit Size Package Size Price Gati-Dex (Gatifloxacin and dexamethasone) (0.5/0.1)% 5mL 20 bottles $400 per box Prednisolone Acetate Preservative-Free 1% 5mL 20 bottles $400 per box Mydriatic 3 Coming Soon (1/1/2.5)% 5mL (Tropicamide/Cyclopentolate/Phenylephrine) Mydriatic 4 Coming Soon (Tropicamide/Cyclopentolate/Phenylephrine/ Ketorolac Tromethamine) (1/0.5/2.5/0.5)% 5mL Povidone Iodine Coming Soon 5% 1mL Oral Formulations IV Free Formulations MKO Melt Sublingual Lemon Coming Soon (Midazolam, ketamine HCl and ondansetron) Concentration Unit Size Package Size Price (3/25/2)mg 1 Melt 21 melts $315.00 per box FREE GROUND SHIPPING FOR ALL 503B ORDERS *For professional use only. Imprimis Pharmaceuticals specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. Imprimis Pharmaceuticals does not compound copies of commercially available products. References available upon request. Tri-Moxi, Dex-Moxi-Ketor, Dex-Moxi, Pred-Gati, Pred-Gati-Brom, Pred-Brom, TIM-LAT, TIM-BRIM-DOR, TIM-DOR-LAT, TIM-BRIM-DOR-LAT, MKO Melt, Moxi, Dropless, LessDrops, SSP Technology, Simple Drops, Total Tears, IV Free, and ImprimisRx are trademarks of Imprimis Pharmaceuticals, Inc. 2018 Imprimis Pharmaceuticals, Inc. All Rights Reserved. IMPO0212 1/18 Current version as of 2/1/2018